What is ZOE?
ZOE operates at the intersection of health science and technology, utilizing artificial intelligence and digital platforms to conduct extensive scientific research. The company's mission is to address critical global health challenges, including the impact of nutrition on health, dietary inflammation, and infectious diseases like COVID-19. By enabling large-scale studies, ZOE aims to generate actionable insights that can lead to improved health outcomes worldwide. The recent funding rounds indicate a strong market validation for its approach to personalized health and scientific discovery.
How much funding has ZOE raised?
ZOE has raised a total of $63.2M across 3 funding rounds:
Series A
$10M
Series B
$50.7M
Other Financing Round
$2.5M
Series A (2021): $10M with participation from ThirdStream Partners and Softbank
Series B (2022): $50.7M led by L Catterton, Accomplice, Ahren Innovation Capital, and Daphni
Other Financing Round (2023): $2.5M supported by Steven Bartlett’s Flight Fund
Key Investors in ZOE
L Catterton
L Catterton is a global consumer-focused private equity firm that has made over 275 investments in consumer brands worldwide, suggesting a strategic interest in ZOE's consumer-facing health science applications.
Ahren Innovation Capital
Ahren Innovation Capital invests in transformational companies at the intersection of deep technology and deep science, aligning with ZOE's AI-driven research and health science focus.
Daphni
Daphni is a venture capital firm focused on tech startups with a European focus and international ambitions, indicating a potential interest in ZOE's global health initiatives and technological innovation.
What's next for ZOE?
With its latest major strategic investment and substantial overall capital, ZOE is poised for accelerated growth and expanded research capabilities. This significant backing, particularly following its Series B financing, suggests the company is moving into a scaling phase, likely focusing on broadening its research scope, enhancing its AI-driven platforms, and potentially expanding its global reach. The strategic nature of the recent financing indicates a focus on synergistic partnerships and market penetration, positioning ZOE to further solidify its leadership in data-driven health science.
See full ZOE company page
